CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Podczas EASD 2026SIBIONICS i PharmaSens badają nowe możliwości zautomatyzowanego dostarczania insuliny

ConferencePositive
AI Analysis

Summary

SiBionics presented a concept combining continuous glucose monitoring with automated insulin delivery at the EASD 2026 conference in Milan, in collaboration with PharmaSens.

Importance:3/10
Sentiment:
0.30
conferenceEASD 2026automated insulin deliverycontinuous monitoringdiabetes care

Read the original article

Published by PR Newswire Pharma on October 5, 2026 9:56 AM

Read Original